Evicenter
MarkdownMedical informationP&T meetings
Relutrigine

SCN2A- and SCN8A-related developmental and epileptic encephalopathies

Launch
Not announced
Last updated
68 sources

Section 6 of 6

References

68 sources

  1. Abbott et al. (2024) (opens in a new tab)
  2. Andersen et al. (2025) (opens in a new tab)
  3. Andrews et al. (2023) (opens in a new tab)
  4. Berg et al. (2021) (opens in a new tab)
  5. Berg et al. (2024) (opens in a new tab)
  6. Berg et al. (2025a) (opens in a new tab)
  7. Berg et al. (2025b) (opens in a new tab)
  8. Berg et al. (2025c) (opens in a new tab)
  9. Bialer et al. (2026) (opens in a new tab)
  10. ClinicalTrials.gov NCT05818553 (opens in a new tab)
  11. Cohen et al. (2022) (opens in a new tab)
  12. Conecker et al. (2024a) (opens in a new tab)
  13. Conecker et al. (2024b) (opens in a new tab)
  14. Cutts et al. (2022) (opens in a new tab)
  15. Dalby et al. (2022) (opens in a new tab)
  16. Densmore et al. (2021) (opens in a new tab)
  17. Downs et al. (2024) (opens in a new tab)
  18. DRKS DRKS00032614 (opens in a new tab)
  19. FamilieSCN2A Foundation (opens in a new tab)
  20. FDA Orphan Drug Designations and Approvals (2021) (opens in a new tab)
  21. Frizzo et al. (2025) (opens in a new tab)
  22. Gallop et al. (2021) (opens in a new tab)
  23. GeneReviews (opens in a new tab)
  24. Gjerulfsen et al. (2025) (opens in a new tab)
  25. Goad et al. (2025) (opens in a new tab)
  26. Johannesen et al. (2018) (opens in a new tab)
  27. Johannesen et al. (2021) (opens in a new tab)
  28. Kaat et al. (2025) (opens in a new tab)
  29. Kahlig et al. (2022) (opens in a new tab)
  30. Kamireddy et al. (2025a) (opens in a new tab)
  31. Kamireddy et al. (2025b) (opens in a new tab)
  32. Kamireddy et al. (2026a) (opens in a new tab)
  33. Kamireddy et al. (2026b) (opens in a new tab)
  34. Krey et al. (2022) (opens in a new tab)
  35. Ludwig et al. (2024) (opens in a new tab)
  36. Ludwig et al. (2026) (opens in a new tab)
  37. Magielski et al. (2025) (opens in a new tab)
  38. MedlinePlus (opens in a new tab)
  39. Mesraoua et al. (2026) (opens in a new tab)
  40. Neurology (2023) (opens in a new tab)
  41. Oates et al. (2018) (opens in a new tab)
  42. Pfister et al. (2022) (opens in a new tab)
  43. Pfister et al. (2023a) (opens in a new tab)
  44. Pfister et al. (2023b) (opens in a new tab)
  45. Pfister et al. (2023c) (opens in a new tab)
  46. Praxis Precision Medicines (opens in a new tab)
  47. Praxis Precision Medicines Breakthrough Therapy designation announcement (2025) (opens in a new tab)
  48. Praxis Precision Medicines EMBOLD results announcement (2025) (opens in a new tab)
  49. Praxis Precision Medicines EMBOLD topline results announcement (2024) (opens in a new tab)
  50. Praxis Precision Medicines EMBOLD topline results presentation (2024) (opens in a new tab)
  51. Praxis Precision Medicines extension period announcement (2026) (opens in a new tab)
  52. Praxis Precision Medicines first quarter 2026 Form 10-Q (2026) (opens in a new tab)
  53. Praxis Precision Medicines fourth quarter and full-year 2025 results announcement (2026) (opens in a new tab)
  54. Praxis Precision Medicines NDA acceptance announcement (2026) (opens in a new tab)
  55. Praxis Precision Medicines NDA filing plans announcement (2025) (opens in a new tab)
  56. Praxis Precision Medicines presentation (2025) (opens in a new tab)
  57. Praxis Precision Medicines presentation (2026) (opens in a new tab)
  58. Praxis Precision Medicines second quarter 2026 results announcement (2026) (opens in a new tab)
  59. Praxis Precision Medicines third quarter 2026 results announcement (2026) (opens in a new tab)
  60. Prime Therapeutics (2026) (opens in a new tab)
  61. SCN8A Research Consortium (2025) (opens in a new tab)
  62. Sevinc et al. (2025) (opens in a new tab)
  63. Tan et al. (2026) (opens in a new tab)
  64. The Cute Syndrome Foundation (opens in a new tab)
  65. Wagner et al. (2026) (opens in a new tab)
  66. Wolff et al. (2017) (opens in a new tab)
  67. Xie et al. (2025) (opens in a new tab)
  68. Zeng et al. (2022) (opens in a new tab)